Physicians' propensity to offer genetic testing for Alzheimer's disease: results from a survey. (Q52011179)

19 April 2018

title

Physicians' propensity to offer genetic testing for Alzheimer's disease: results from a survey. (English)

1 reference

19 April 2018

1 reference

2

Gail Geller

0 references

author name string

Gary A Chase

1

1 reference

19 April 2018

Gail Geller

2

1 reference

19 April 2018

Suzanne L Havstad

3

1 reference

19 April 2018

Neil A Holtzman

4

1 reference

19 April 2018

Susan Spear Bassett

5

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 July 2002

1 reference

19 April 2018

published in

Genetics in Medicine

1 reference

19 April 2018

volume

4

1 reference

19 April 2018

page(s)

297-303

1 reference

19 April 2018

issue

4

1 reference

19 April 2018

https://scigraph.springernature.com/pub.10.1097/00125817-200207000-00008

exact match

0 references

cites work

Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Age-specific incidence of Alzheimer's disease in a community population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Assessment of genetic risk for Alzheimer's disease among first-degree relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Age at onset and familial risk in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Predisposing locus for Alzheimer's disease on chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Molecular genetics of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

APOE is a major susceptibility gene for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

The genetics of Alzheimer disease and the application of molecular tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Improving response rates through incentive and follow-up: the effect on a survey of physicians' knowledge of genetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Statement on Use of Apolipoprotein E Testing for Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

APOE genotyping in differential diagnosis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Risk of dementia in relatives of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

Physicians' knowledge of genetics and genetic tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00008

10.1097/00125817-200207000-00008

21 January 2018

Identifiers

DOI

1 reference

19 April 2018

Dimensions Publication ID

0 references

1 reference

19 April 2018